Published in J Viral Hepat on October 17, 2011
Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers. PLoS One (2013) 1.16
MicroRNAs activate natural killer cells through Toll-like receptor signaling. Blood (2013) 1.15
PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs. PPAR Res (2012) 1.03
Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B. PLoS One (2013) 1.00
MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy. PLoS One (2014) 0.92
Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycle. PLoS One (2012) 0.90
Serum microRNA-122 predicts survival in patients with liver cirrhosis. PLoS One (2012) 0.88
HBx down-regulated Gld2 plays a critical role in HBV-related dysregulation of miR-122. PLoS One (2014) 0.88
Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study. BMC Med Genomics (2015) 0.86
Roles of microRNAs in the hepatitis B virus infection and related diseases. Viruses (2013) 0.85
Complex interactions between microRNAs and hepatitis B/C viruses. World J Gastroenterol (2014) 0.83
Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies. World J Gastroenterol (2014) 0.82
Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis. PLoS One (2015) 0.81
MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects. World J Gastroenterol (2014) 0.81
MicroRNAs associated with HBV infection and HBV-related HCC. Theranostics (2014) 0.81
MicroRNAs may solve the mystery of chronic hepatitis B virus infection. World J Gastroenterol (2013) 0.80
Circulating MicroRNAs as Biomarkers for Sepsis. Int J Mol Sci (2016) 0.80
Severity of hepatitis C virus (genotype-3) infection positively correlates with circulating microRNA-122 in patients sera. Dis Markers (2014) 0.80
Serum miR-181b Is Correlated with Hepatitis B Virus Replication and Disease Progression in Chronic Hepatitis B Patients. Dig Dis Sci (2015) 0.79
Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis. J Appl Toxicol (2013) 0.79
Hepatitis B surface antigen quantity positively correlates with plasma levels of microRNAs differentially expressed in immunological phases of chronic hepatitis B in children. PLoS One (2013) 0.78
Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players. Curr Pathobiol Rep (2014) 0.78
MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations. Biomark Insights (2016) 0.77
A Pilot Study of MicroRNAs Expression Profile in Serum and HBsAg Particles: Predictors of Therapeutic Vaccine Efficacy in Chronic Hepatitis B Patients. Medicine (Baltimore) (2016) 0.76
MicroRNAs in Liver Disease: Bench to Bedside. J Clin Exp Hepatol (2013) 0.76
Circulating ECV-Associated miRNAs as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis. Front Pharmacol (2017) 0.75
MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin. Sci Rep (2016) 0.75
Circulating microRNAs as Potential Biomarkers of Infectious Disease. Front Immunol (2017) 0.75
Serum microRNA-30c levels are correlated with disease progression in Xinjiang Uygur patients with chronic hepatitis B. Braz J Med Biol Res (2017) 0.75
Identification and characterization of interferon signaling-related microRNAs in occult hepatitis B virus infection. Clin Epigenetics (2017) 0.75
On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun (1967) 18.32
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med (1998) 6.23
Maturation of the immune response in germinal centers. Cell (1991) 5.68
Why doesn't audit work? BMJ (1998) 5.63
Private company wins rights to Icelandic gene database. BMJ (1999) 4.04
Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis. Aliment Pharmacol Ther (2014) 3.91
Mapping the active site of papain with the aid of peptide substrates and inhibitors. Philos Trans R Soc Lond B Biol Sci (1970) 3.29
On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. Biochem Biophys Res Commun (1968) 3.10
Silicon nanowire-based solar cells on glass: synthesis, optical properties, and cell parameters. Nano Lett (2009) 2.41
Endoscopic transhiatal drainage of a mediastinal pancreatic pseudocyst. Endoscopy (2004) 2.34
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat (2011) 2.30
Detection of Herpes simplex virus DNA by real-time PCR. J Clin Microbiol (2000) 2.29
Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med (1984) 2.26
Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol (1998) 2.25
Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study. Aliment Pharmacol Ther (2014) 2.18
Conformational studies of poly-L-alanine in water. Biopolymers (1968) 2.02
Position-dependent accommodative shift of retropupillary fixated iris-claw lenses. Graefes Arch Clin Exp Ophthalmol (2012) 2.00
The interfascicular nerve-grafting of the median and ulnar nerves. J Bone Joint Surg Am (1972) 1.82
Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun (1996) 1.82
Pilonidal sinus disease. J Visc Surg (2013) 1.76
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Persistence of pedicle blood flow up to 10 years after free musculocutaneous tissue transfer. Plast Reconstr Surg (1998) 1.67
Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays. Hepatology (2000) 1.64
On estimating recessive frequencies from truncated samples. Biometrics (1967) 1.62
Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry as a tool for rapid diagnosis of potentially toxigenic Corynebacterium species in the laboratory management of diphtheria-associated bacteria. Euro Surveill (2010) 1.60
Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol (2000) 1.59
Cystic retroperitoneal lymphangiomas in adults. Eur J Surg Oncol (1997) 1.59
Neonatal urinary uric acid/creatinine [correction of ceratinine] ratio as an additional marker of perinatal asphyxia. Eur J Pediatr (1995) 1.59
Stability of the Astronomical Frequencies Over the Earth's History for Paleoclimate Studies. Science (1992) 1.54
The purification of papain by affinity chromatography. Eur J Biochem (1970) 1.52
Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol (1999) 1.51
Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr (2000) 1.51
High tie versus low tie vascular ligation of the inferior mesenteric artery in colorectal cancer surgery: impact on the gain in colon length and implications on the feasibility of anastomoses. Dis Colon Rectum (2012) 1.51
Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound. Ultraschall Med (2011) 1.50
Malignant degeneration in Madelung's disease (benign lipomatosis of the neck): case report. Br J Plast Surg (1983) 1.46
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. J Viral Hepat (2013) 1.46
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. J Hepatol (2011) 1.45
A case-control study of risk factors for intraoperative suprachoroidal expulsive hemorrhage. Ophthalmology (1991) 1.45
Hepatitis delta: on soft paws across Germany. Infection (2012) 1.43
Giant and reversible extrinsic magnetocaloric effects in La0.7Ca0.3MnO3 films due to strain. Nat Mater (2012) 1.43
Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients. Transfusion (1997) 1.42
Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs. J Viral Hepat (2012) 1.42
Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a. J Clin Microbiol (2001) 1.42
Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal. Int J Radiat Oncol Biol Phys (2001) 1.41
Profiling left and right ventricular proportional output during fetal life with a novel systolic index in the aortic isthmus. Ultrasound Obstet Gynecol (2014) 1.39
On the size of the active site in proteases. II. Carboxypeptidase-A. Biochem Biophys Res Commun (1967) 1.39
How accurate is serologic testing of plasma pools for hepatitis B virus surface antigen, anti-human immunodeficiency virus 1 and 2, and anti-hepatitis C virus? Infusionsther Transfusionsmed (1996) 1.39
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. J Viral Hepat (2013) 1.37
Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis. Aliment Pharmacol Ther (2008) 1.36
Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy. Aliment Pharmacol Ther (2010) 1.36
Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy. AIDS (1999) 1.33
Taxol produces a predominantly sensory neuropathy. Neurology (1989) 1.32
Gram type-specific broad-range PCR amplification for rapid detection of 62 pathogenic bacteria. J Clin Microbiol (1999) 1.32
The fasciocutaneous supraclavicular artery island flap for releasing postburn mentosternal contractures. Plast Reconstr Surg (1997) 1.31
Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem (1996) 1.31
Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load. J Clin Microbiol (2006) 1.29
A nuclear mutant of Arabidopsis with impaired stability on distinct transcripts of the plastid psbB, psbD/C, ndhH, and ndhC operons. Plant Cell (1996) 1.28
Involvement of a pertussis toxin-sensitive G protein in the mitogenic signaling pathways of sphingosine 1-phosphate. J Biol Chem (1995) 1.27
Retroperitoneal endoscopic debridement for infected peripancreatic necrosis. Lancet (2000) 1.26
Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med (2001) 1.26
[Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline]. Z Gastroenterol (2011) 1.24
Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol (2001) 1.23
Inhibition of return in spatial attention: direct evidence for collicular generation. Nat Neurosci (1999) 1.21
Real-time elastography and contrast-enhanced ultrasound for the assessment of thyroid nodules. Exp Clin Endocrinol Diabetes (2009) 1.21
Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta. Eur J Immunol (1991) 1.20
Macromolecular mechanisms of sputum inhibition of tobramycin activity. Antimicrob Agents Chemother (1995) 1.19
Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol (2001) 1.19
A treadmill ergometer for three-dimensional ground reaction forces measurement during walking. J Biomech (2001) 1.18
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]. Z Gastroenterol (2012) 1.17
SNAP-23 is not cleaved by botulinum neurotoxin E and can replace SNAP-25 in the process of insulin secretion. J Biol Chem (1997) 1.17
QTL detection by multi-parent linkage mapping in oil palm (Elaeis guineensis Jacq.). Theor Appl Genet (2010) 1.17
Polymers tripeptides as collagen models. II. Conformational changes of poly(L-prolyl-glycyl-L-prolyl) in solution. J Mol Biol (1966) 1.16
Hepatitis C virus kinetics. Antivir Ther (2000) 1.15
Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer. Ann Intern Med (2001) 1.15
Review article: predicting response in hepatitis C virus therapy. Aliment Pharmacol Ther (2006) 1.15
A revolution in drug discovery. Combinatorial chemistry still needs logic to drive science forward. BMJ (2000) 1.14
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial. Ann Oncol (2007) 1.12
Inositol 1,4,5-trisphosphate and 5'-GTP induce calcium release from different intracellular pools. FEBS Lett (1987) 1.12
Action on clinical audit: progress report. BMJ (1998) 1.12
Modulation of interleukin-18 expression in human colon carcinoma: consequences for tumor immune surveillance. Int J Cancer (1999) 1.11
Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology (1997) 1.11
Phantoms in the brain. Question the assumption that the adult brain is "hard wired". BMJ (1999) 1.11
Retinal pigment epithelial repopulation in monkeys after submacular surgery. Arch Ophthalmol (1995) 1.11
A dipeptidocarboxypeptidase from E. coli. Biochem Biophys Res Commun (1972) 1.11
Lysine oligopeptides. Preparation by ion-exchange chromatography. Biopolymers (1972) 1.11
Multicenter evaluation of a new rapid automated human immunodeficiency virus antigen detection assay. J Virol Methods (1999) 1.11
Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response. Hepatology (2000) 1.10
Attitudes of high school girls in Israel and the United States toward breast feeding. J Adolesc Health Care (1985) 1.10
Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors. Involvement of sphingosine 1-phosphate in PDGF but not EGF signaling. J Biol Chem (1997) 1.10
Synthetic polypeptides as substrates and inhibitors of collagen proline hydroxylase. Arch Biochem Biophys (1968) 1.10
Th1 and Th2 responses: what are they? BMJ (2000) 1.09